AbbVie Inc. (NYSE:ABBV)

Pills

Short Sellers Have Mixed Feelings on Major Pharma

The short interest data have been released for the August 14 settlement date. Pharmaceutical companies are usually involved in a lengthy process in getting their drug candidates to market through ...
Read Full Story »
Prescription drugs

4 Top Pharma Stocks That Should Outperform Out To 2016

With a very nervous market, and the end of summer doldrums upon us, it may be time to look for ideas that will make sense when the market heats back ...
Read Full Story »
Prescription drugs

Short Sellers Back Off Big Pharma

The short interest data have been released for the July 31 settlement date. Pharmaceutical companies are usually involved in a lengthy process in getting their drug candidates to market through ...
Read Full Story »
biotech

Why AbbVie Should Be Worth 25% More

AbbVie Inc. (NYSE: ABBV) continues to make headwinds in being recognized on its own as its own independent outfit. With shares trading around $69.00 now, one analyst sees over 25% ...
Read Full Story »
Prescription drugs

Short Sellers Run For Cover From Major Pharma

The short interest data have been released for the July 15 settlement date. Pharmaceutical companies are usually involved in a lengthy process in getting their drug candidates to market through ...
Read Full Story »
Money background. Close-up.

Are AbbVie Earnings Enough?

AbbVie Inc. (NYSE: ABBV) reported its second-quarter financial results Friday before the markets opened. The pharmaceutical giant had $1.08 in earnings per share (EPS) on $5.48 billion in revenue. That ...
Read Full Story »
generic drugs

What to Expect From AbbVie Earnings

AbbVie Inc. (NYSE: ABBV) is scheduled to report its second-quarter financial results before the markets open Friday. The consensus estimates from Thomson Reuters call for $1.06 in earnings per share ...
Read Full Story »
biotech

Top Health Care Earnings for the Week Ahead

Earnings season is hitting its stride next week, and we have taken a look at companies in a variety of sectors that will be posting results next week. The health ...
Read Full Story »
Eli Lilly Logo

3 Top Big Pharmaceutical Stocks With Upcoming Catalysts

While it appears at least for the time being that the Greek can once again has been kicked down the road, looking for solid more defensive stocks still makes good ...
Read Full Story »
Pills

Short Sellers Run for Cover in Big Pharma

The short interest data have been released for the June 30 settlement date. Pharmaceutical companies are usually involved in a lengthy process in getting their drug candidates to market through ...
Read Full Story »
Pfizer logo

3 UBS Must-Own Large-Cap Pharmaceutical Stocks

Anytime you see warning clouds hovering over the stock market like we may be seeing now, there are two really good options. Sell stocks and raise cash to take advantage ...
Read Full Story »
Pills

Is Big Pharma Advertising Getting Out of Control?

How much are big pharmaceutical companies really spending to get their drugs out there in the public eye? In 2014, these companies spent about $4.5 billion in advertising alone, notably ...
Read Full Story »
Pills

Short Sellers Become More Focused on Big Pharma

The short interest data has been released for the June 15 settlement date. Pharmaceutical companies are usually involved in a lengthy process in getting their drug candidates to market through ...
Read Full Story »
GoogleLogo

Jefferies Franchise Stock Picks Crush S&P 500: 4 to Buy Now

The rage for the past 10 to 15 years has been to index. Stock picking, once the trademark of such great managers as Peter Lynch and Bill Miller, was pushed ...
Read Full Story »
Prescription drugs

Short Sellers Back Off Big Pharma

The short interest data has been released for the May 29 settlement date. Pharmaceutical companies are usually involved in a lengthy process in getting their drug candidates to market through ...
Read Full Story »